Titre : Inhibiteur tissulaire de métalloprotéinase-1

Inhibiteur tissulaire de métalloprotéinase-1 : Questions médicales fréquentes

Termes MeSH sélectionnés :

Flow Cytometry
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Inhibiteur tissulaire de métalloprotéinase-1 : Questions médicales les plus fréquentes", "headline": "Inhibiteur tissulaire de métalloprotéinase-1 : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Inhibiteur tissulaire de métalloprotéinase-1 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-08", "dateModified": "2025-04-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Inhibiteur tissulaire de métalloprotéinase-1" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Inhibiteur tissulaire des métalloprotéinases", "url": "https://questionsmedicales.fr/mesh/D019714", "about": { "@type": "MedicalCondition", "name": "Inhibiteur tissulaire des métalloprotéinases", "code": { "@type": "MedicalCode", "code": "D019714", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.815.875" } } }, "about": { "@type": "MedicalCondition", "name": "Inhibiteur tissulaire de métalloprotéinase-1", "alternateName": "Tissue Inhibitor of Metalloproteinase-1", "code": { "@type": "MedicalCode", "code": "D019715", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anna Pryczynicz", "url": "https://questionsmedicales.fr/author/Anna%20Pryczynicz", "affiliation": { "@type": "Organization", "name": "Department of Pathomorphology, Medical University of Bialystok, Bialystok, Poland." } }, { "@type": "Person", "name": "Adina Elena Stanciu", "url": "https://questionsmedicales.fr/author/Adina%20Elena%20Stanciu", "affiliation": { "@type": "Organization", "name": "Department of Carcinogenesis and Molecular Biology, 'Prof. Dr. Alexandru Trestioreanu' Institute of Oncology, 022328 Bucharest, Romania." } }, { "@type": "Person", "name": "Adina Zamfir-Chiru-Anton", "url": "https://questionsmedicales.fr/author/Adina%20Zamfir-Chiru-Anton", "affiliation": { "@type": "Organization", "name": "ENT Department, 'Grigore Alexandrescu' Children's Emergency Hospital, 011743 Bucharest, Romania." } }, { "@type": "Person", "name": "Marcel Marian Stanciu", "url": "https://questionsmedicales.fr/author/Marcel%20Marian%20Stanciu", "affiliation": { "@type": "Organization", "name": "Electrical Engineering Faculty, 'Politehnica' University, 060042 Bucharest, Romania." } }, { "@type": "Person", "name": "Mirela Gherghe", "url": "https://questionsmedicales.fr/author/Mirela%20Gherghe", "affiliation": { "@type": "Organization", "name": "Department of Nuclear Medicine, 'Prof. Dr. Alexandru Trestioreanu' Institute of Oncology, 022328 Bucharest, Romania." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Subendometrial blood flow detected by Doppler ultrasound associates with pregnancy outcomes of frozen embryo transfer in patients with thin endometrium.", "datePublished": "2024-09-14", "url": "https://questionsmedicales.fr/article/39276274", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10815-024-03245-z" } }, { "@type": "ScholarlyArticle", "name": "Development of aptamer-based lateral flow devices for rapid detection of SARS-CoV-2 S protein and uncertainty assessment.", "datePublished": "2024-09-07", "url": "https://questionsmedicales.fr/article/39276574", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.talanta.2024.126825" } }, { "@type": "ScholarlyArticle", "name": "Investigation of co-flow step emulsification (CFSE) microfluidic device and its applications in digital polymerase chain reaction (ddPCR).", "datePublished": "2024-09-02", "url": "https://questionsmedicales.fr/article/39255752", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jcis.2024.08.251" } }, { "@type": "ScholarlyArticle", "name": "Altered muscle fibre activation in an antagonistic muscle pair due to perturbed afferent feedback caused by blood flow restriction.", "datePublished": "2024-08-27", "url": "https://questionsmedicales.fr/article/39244815", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jelekin.2024.102922" } }, { "@type": "ScholarlyArticle", "name": "Novel Fe/Ca oxide co-embedded coconut shell biochar for phosphorus recovery from agricultural return flows.", "datePublished": "2024-08-27", "url": "https://questionsmedicales.fr/article/39193306", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1039/d4ra04795h" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines sécrétoires inhibitrices de protéinases", "item": "https://questionsmedicales.fr/mesh/D053491" }, { "@type": "ListItem", "position": 5, "name": "Inhibiteur tissulaire des métalloprotéinases", "item": "https://questionsmedicales.fr/mesh/D019714" }, { "@type": "ListItem", "position": 6, "name": "Inhibiteur tissulaire de métalloprotéinase-1", "item": "https://questionsmedicales.fr/mesh/D019715" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Inhibiteur tissulaire de métalloprotéinase-1 - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Inhibiteur tissulaire de métalloprotéinase-1", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Inhibiteur tissulaire de métalloprotéinase-1", "description": "Comment diagnostiquer une anomalie de TIMP-1 ?\nQuels symptômes indiquent un déséquilibre de TIMP-1 ?\nY a-t-il des biomarqueurs associés à TIMP-1 ?\nQuel rôle joue TIMP-1 dans le cancer ?\nComment TIMP-1 est-il mesuré en clinique ?", "url": "https://questionsmedicales.fr/mesh/D019715?mesh_terms=Flow+Cytometry&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Inhibiteur tissulaire de métalloprotéinase-1", "description": "Quels symptômes sont liés à une surproduction de TIMP-1 ?\nTIMP-1 affecte-t-il la cicatrisation des plaies ?\nQuels signes indiquent une carence en TIMP-1 ?\nY a-t-il des symptômes associés à des maladies inflammatoires ?\nComment TIMP-1 influence-t-il l'inflammation ?", "url": "https://questionsmedicales.fr/mesh/D019715?mesh_terms=Flow+Cytometry&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Inhibiteur tissulaire de métalloprotéinase-1", "description": "Peut-on prévenir les déséquilibres de TIMP-1 ?\nQuels facteurs de mode de vie influencent TIMP-1 ?\nY a-t-il des recommandations pour maintenir TIMP-1 ?\nLes suppléments peuvent-ils aider TIMP-1 ?\nComment le suivi médical aide-t-il TIMP-1 ?", "url": "https://questionsmedicales.fr/mesh/D019715?mesh_terms=Flow+Cytometry&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Inhibiteur tissulaire de métalloprotéinase-1", "description": "Quels traitements ciblent TIMP-1 ?\nTIMP-1 peut-il être utilisé comme cible thérapeutique ?\nQuels médicaments influencent TIMP-1 ?\nY a-t-il des essais cliniques sur TIMP-1 ?\nComment les traitements affectent-ils TIMP-1 ?", "url": "https://questionsmedicales.fr/mesh/D019715?mesh_terms=Flow+Cytometry&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Inhibiteur tissulaire de métalloprotéinase-1", "description": "Quelles complications peuvent survenir avec un excès de TIMP-1 ?\nTIMP-1 est-il lié à des maladies chroniques ?\nComment TIMP-1 affecte-t-il la santé cardiovasculaire ?\nY a-t-il des risques de cancer liés à TIMP-1 ?\nQuels effets secondaires peuvent résulter d'un traitement de TIMP-1 ?", "url": "https://questionsmedicales.fr/mesh/D019715?mesh_terms=Flow+Cytometry&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Inhibiteur tissulaire de métalloprotéinase-1", "description": "Quels facteurs augmentent le risque de déséquilibre de TIMP-1 ?\nLes maladies auto-immunes influencent-elles TIMP-1 ?\nLe stress a-t-il un impact sur TIMP-1 ?\nL'alimentation joue-t-elle un rôle dans TIMP-1 ?\nY a-t-il un lien entre TIMP-1 et l'inactivité physique ?", "url": "https://questionsmedicales.fr/mesh/D019715?mesh_terms=Flow+Cytometry&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie de TIMP-1 ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins mesurant les niveaux de TIMP-1 peuvent être effectués." } }, { "@type": "Question", "name": "Quels symptômes indiquent un déséquilibre de TIMP-1 ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'inflammation ou des troubles de cicatrisation peuvent survenir." } }, { "@type": "Question", "name": "Y a-t-il des biomarqueurs associés à TIMP-1 ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des biomarqueurs comme le collagène et les métalloprotéinases sont souvent étudiés." } }, { "@type": "Question", "name": "Quel rôle joue TIMP-1 dans le cancer ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "TIMP-1 peut inhiber la progression tumorale en régulant la dégradation de la matrice." } }, { "@type": "Question", "name": "Comment TIMP-1 est-il mesuré en clinique ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il est mesuré par des tests immunologiques spécifiques dans des échantillons de sang." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une surproduction de TIMP-1 ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction peut entraîner des douleurs articulaires et une fibrose tissulaire." } }, { "@type": "Question", "name": "TIMP-1 affecte-t-il la cicatrisation des plaies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un excès de TIMP-1 peut ralentir la cicatrisation des plaies." } }, { "@type": "Question", "name": "Quels signes indiquent une carence en TIMP-1 ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Une carence peut se manifester par une dégradation excessive de la matrice extracellulaire." } }, { "@type": "Question", "name": "Y a-t-il des symptômes associés à des maladies inflammatoires ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des maladies comme l'arthrite peuvent être liées à des niveaux anormaux de TIMP-1." } }, { "@type": "Question", "name": "Comment TIMP-1 influence-t-il l'inflammation ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "TIMP-1 peut moduler l'inflammation en régulant les métalloprotéinases impliquées." } }, { "@type": "Question", "name": "Peut-on prévenir les déséquilibres de TIMP-1 ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à maintenir l'équilibre." } }, { "@type": "Question", "name": "Quels facteurs de mode de vie influencent TIMP-1 ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme et l'obésité peuvent affecter les niveaux de TIMP-1." } }, { "@type": "Question", "name": "Y a-t-il des recommandations pour maintenir TIMP-1 ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Pratiquer une activité physique régulière et gérer le stress sont recommandés." } }, { "@type": "Question", "name": "Les suppléments peuvent-ils aider TIMP-1 ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments antioxydants peuvent soutenir la régulation de TIMP-1." } }, { "@type": "Question", "name": "Comment le suivi médical aide-t-il TIMP-1 ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier permet de détecter et de corriger les déséquilibres de TIMP-1." } }, { "@type": "Question", "name": "Quels traitements ciblent TIMP-1 ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des inhibiteurs spécifiques sont en cours d'étude." } }, { "@type": "Question", "name": "TIMP-1 peut-il être utilisé comme cible thérapeutique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en régulant TIMP-1, on peut potentiellement traiter certaines pathologies." } }, { "@type": "Question", "name": "Quels médicaments influencent TIMP-1 ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains anti-inflammatoires peuvent moduler l'expression de TIMP-1." } }, { "@type": "Question", "name": "Y a-t-il des essais cliniques sur TIMP-1 ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, plusieurs essais cliniques explorent son rôle dans diverses maladies." } }, { "@type": "Question", "name": "Comment les traitements affectent-ils TIMP-1 ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent soit augmenter, soit diminuer les niveaux de TIMP-1 selon le contexte." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec un excès de TIMP-1 ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Un excès peut entraîner des maladies fibrosantes et des troubles cardiovasculaires." } }, { "@type": "Question", "name": "TIMP-1 est-il lié à des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de TIMP-1 sont associés à des maladies chroniques comme le diabète." } }, { "@type": "Question", "name": "Comment TIMP-1 affecte-t-il la santé cardiovasculaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de TIMP-1 peuvent contribuer à l'athérosclérose." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer liés à TIMP-1 ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux élevés de TIMP-1 peuvent être associés à une progression tumorale." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent résulter d'un traitement de TIMP-1 ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent entraîner des effets secondaires comme des réactions allergiques." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de déséquilibre de TIMP-1 ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, le tabagisme et l'obésité sont des facteurs de risque connus." } }, { "@type": "Question", "name": "Les maladies auto-immunes influencent-elles TIMP-1 ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies auto-immunes peuvent perturber l'équilibre de TIMP-1." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur TIMP-1 ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter les niveaux de TIMP-1 dans l'organisme." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans TIMP-1 ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en graisses saturées peut perturber les niveaux de TIMP-1." } }, { "@type": "Question", "name": "Y a-t-il un lien entre TIMP-1 et l'inactivité physique ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'inactivité physique peut contribuer à des déséquilibres de TIMP-1." } } ] } ] }

Sources (10000 au total)

Subendometrial blood flow detected by Doppler ultrasound associates with pregnancy outcomes of frozen embryo transfer in patients with thin endometrium.

Multiple factors have been shown to influence the rate of clinical pregnancy after FET in IVF treatment, including embryo quality, synchronization of embryo and endometrium, and endometrial receptivit... This was a retrospective cohort study conducted at a university-affiliated reproductive hospital from January 2017 to April 2023. The EMT and subendometrial blood flows were assessed using transvagina... In the patients with 0.5 cm ≤ EMT ≤ 0.7 cm, the embryo implantation rate was statistically significant increased in the patients with the presence of subendometrial blood flow (OR 1.484; 95% CI, 1.001... The presence of subendometrial blood flow detected by ultrasound was positively associated with successful embryo implantation and favorable pregnancy outcomes in patients with thin endometrium underg...

Investigation of co-flow step emulsification (CFSE) microfluidic device and its applications in digital polymerase chain reaction (ddPCR).

The co-flow step emulsification (CFSE) is very sensitive to the two-phase fluid interfaces, we conjecture that the CFSE hydrodynamic model depends on several key factors and the droplet generation pro... By combining numerical simulation and fluid dynamics experiments, we have investigated the crucial parameters affecting the CFSE two-phase interface and finally achieved the prediction and guidance fo... With the help of the CFSE device, multivolume droplet populations were produced on demand. Then, ddPCR tests were performed with DNA concentrations from 10 copies/μL to 20,000 copies/μL. The CFSE devi...

Altered muscle fibre activation in an antagonistic muscle pair due to perturbed afferent feedback caused by blood flow restriction.

This study aimed to better understand the coping strategy of the neuromuscular system under perturbed afferent feedback. To this end, the neuromechanical effects of transient blood flow restriction (B... Perceived discomfort and neuromechanical parameters (torque and high-density electromyography) were recorded during submaximal isometric ankle dorsiflexion before, during and after BFR. The tibialis a... Discomfort increased during BFR and decreased to baseline level afterwards. The exerted torque and the co-activation index remained constant, whereas the EMG signal energy increased significantly duri... Perturbed afferent feedback leads to altered neuromechanical parameters. We assume that increased central drive is required to maintain force output, resulting in changed muscle fibre activity. Glycol...

Effect of a four-week oral Phe administration on neural activation and cerebral blood flow in adults with early-treated phenylketonuria.

Phenylketonuria (PKU) is a rare inborn error of metabolism characterized by impaired catabolism of the amino acid phenylalanine (Phe) into tyrosine. Cross-sectional studies suggest slight alterations ... We conducted a randomized, placebo-controlled, double-blind, crossover, non-inferiority trial to assess the effect of a high Phe load on working memory-related neural activation and CBF in early-treat... Plasma Phe and cerebral Phe were significantly increased after the Phe intervention. However, no significant effect of Phe compared to placebo was found on neural activation and CBF. Regarding fMRI ta... Results from this present trial simulating a four-week discontinuation of the Phe-restricted diet showed that a high Phe load did not uniformly affect neural markers and cognition in a statistically s...

Impact of high-flow oxygen therapy via high velocity nasal insufflation on diaphragmatic thickening fraction in healthy subjects.

The primary objective of this study was to evaluate the impact of high-flow nasal cannula oxygen therapy [HFNC] on the diaphragm thickening fraction.... Prospective, descriptive, cohort study SETTING: The study was conducted in the Physiology and Respiratory Care Laboratory, Intensive Care Unit, Hospital Británico de Buenos Aires.... Thirteen healthy subjects >18 years old INTERVENTIONS: High-flow nasal cannula oxygen therapy MAIN VARIABLES OF INTEREST: Demographic data (age and gender), anthropometric data (weight, height, and bo... Median DTf decreased significantly as flow increased (p < 0.05). The baseline DTf measurement was 21.4 %, 18.3 % with 20 L/m, and 16.4 % with 40 L/m. We also observed a significant decrease in RR as f... The use of high-flow oxygen therapy through nasal cannula of HFNC in healthy subjects decreases the DTf and RR in association with increased flow. In addition, the use of 40 L/m flow may reduce the mu...